Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | CCL2 | P13500 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15987500 | 0.74 | HTR2A (0.38) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL13782351 | 0.74 | HTR2A (0.38) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL13782587 | 0.74 | HTR2A (0.38) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL4295538 | 0.74 | HTR2A (0.38) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL10578702 | 0.74 | HTR2A (0.38) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL2640847 | 0.74 | HTR2A (0.42) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL28774778 | 0.74 | RET (0.39) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL29768305 | 0.74 | PRCP (0.41) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL28774801 | 0.74 | PRCP (0.41) | BRD4CCL2HTR2AKDM4ECYP2D6 | |
| SCHEMBL29768307 | 0.74 | RET (0.39) | BRD4CCL2HTR2AKDM4ECYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116200357-A | Imine reductase mutant and application thereof in synthesis of chiral tetrahydroisoquinoline | 中国科学院天津工业生物技术研究所 | 2023-06-02 | — | — | CN | claimed |
| CN-102834394-B | Bicyclic quinolone compounds, preparation and application thereof | KBP BIOSCIENCES CO LTD | 2015-03-25 | — | — | CN | disclosed |
| CN-102212056-A | Novel bicyclo-carbostyril compounds | KBP BIOSCIENCES CO LTD | 2011-10-12 | — | — | CN | disclosed |
| US-20100120855-A1 | MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARMACEUTICALS LTD. | 2010-05-13 | — | — | US | disclosed |
| WO-2005058857-A1 | TETRONIC AND TETRAMIC ACIDS AS INHIBITORS OF BETA-SECREASE | F. HOFFMANN-LA ROCHE AG (CH) | 2005-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120855-A1 | MACROCYLIC INHIBITORS OF HEPATITIS C VIRUS | NR4A1, NR4A3, NR4A2 | BRD4 320/4885CCL2 1392/4885HTR2A 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.